APOE epsilon status in Hungarian patients with primary progressive multiple sclerosis

作者:Losonczi Erika; Bencsik Krisztina; Nagy Zsanett Fricska; Honti Viktor; Szalczer Estilla; Rajda Cecilia; Illes Zsolt; Matyas Klotild; Rozsa Csilla; Csepany Tuende; Fuevesi Judit; Vecsei Laszlo*
来源:Swiss Medical Weekly, 2010, 140: w13119.
DOI:10.4414/smw.2010.13119

摘要

PRINCIPLES: Apolipoprotein E (ApoE), an important glycoprotein in the transport, uptake and redistribution of cholesterol, is necessary in nerve tissue repair. The APOE gene (APOE) is involved in neurodegenerative diseases, the best-known association being that between the APOE epsilon 4 allele and Alzheimer's disease. Multiple sclerosis (MS) is a chronic inflammatory neurological disease. The aim of this study was to assess (multicentre assessment) the possible influence of the APOE gene on the susceptibility of primary progressive MS (PPMS) in Hungary. METHODS: Polymerase chain reaction and restriction fragment length polymorphism were carried out on DNA isolated from 135 volunteers. RESULTS: The number of PPMS patients without the epsilon 2 allele was found to be remarkably high, whilst the epsilon 2 allele was overrepresented in the RRMS group. A markedly high frequency of the epsilon 4 allele was found in the PPMS group and a very low frequency in the HC group. With regards to the clinical parameters, significant differences were observed between the RRMS and PPMS groups. Differences were also detected regarding the EDSS and MSSS scores when the patients were grouped by the presence or absence of the epsilon 2 allele. All of the observed differences in the clinical parameters disappeared when the patients were further stratified by the type of MS. CONCLUSIONS: Our findings suggest that the presence of the epsilon 2 and epsilon 4 alleles may play a role in the development of the disease. However, if any type of the disease has already developed the alleles show no association with the clinical parameters.

  • 出版日期2010-11-26